Mumbai, 21 November (Udaipur Kiran). Alembic Pharmaceuticals emerged as the leading gainer in the BSE Group A category on Thursday. The stock was trading at ₹941.75, up ₹43.00 or 4.78% from its previous close of ₹898.75.
The scrip opened at ₹916.95 and moved within a range of ₹958.50 and ₹901.30 during the session. Over 82,700 shares have been traded so far.
The stock has a 52-week high of ₹1,122.40 recorded on 6 January 2025 and a 52-week low of ₹725.60 on 3 March 2025. In the past week, it has traded between ₹958.50 and ₹890.90. The company currently commands a market capitalisation of ₹18,647.94 crore.
Promoters hold 69.74% stake in Alembic Pharmaceuticals, while institutional investors own 20.35% and non-institutional shareholders hold 9.92%.
Other notable gainers in the Group A list include Anupam Rasayan India (up 4.76%), TBO Tek (up 4.67%), and Kesoram Industries (up 4.36%).
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
